CAS 444731-52-6 Pazopanib powder Pazopanib (FREE BASE) for Research

CAS 444731-52-6 Pazopanib powder Pazopanib (FREE BASE) for Research

Pazopanib is an oral medication that belongs to a class of drugs known as tyrosine kinase inhibitors. It is primarily used in the treatment of certain types of cancer, including advanced renal cell carcinoma (kidney cancer), soft tissue sarcoma, and advanced ovarian cancer.

Pazopanib works by inhibiting the activity of specific proteins called tyrosine kinases, which play a crucial role in the growth and spread of cancer cells. By blocking these proteins, pazopanib helps to slow down or stop the growth of tumors.

Patients typically take pazopanib once a day, with or without food. The exact dosage and duration of treatment may vary depending on the specific type and stage of cancer being treated, as well as individual patient factors.

Like any medication, pazopanib can cause side effects. Common side effects may include fatigue, diarrhea, high blood pressure, nausea, vomiting, and loss of appetite. It is important for patients to discuss any side effects or concerns with their healthcare provider.

Xingtai Xinzhou Technology Co., LTD.

Xingtai Xinzhou Technology Co., Ltd. was established in 2022 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures. Effectively promote the joint venture and cooperation with the major enterprises, manufacturers, with the idea of industrial development to serve the society and the majority of users. We always adhere to the market demand as the orientation, constantly synthesizing new high-tech chemical products and medical intermediates, mainly exported to the United States, India, South Africa, Nigeria and other countries and regions, has a wealth of export experience, to ensure transportation safety, can let each customer as soon as possible to safely receive the goods.